Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

By Endrikat J.   Gerlinger C.   Cronin M.   Wessel J.   Ruebig A.   Rosenbaum P.   Düsterberg B.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 4, 2001-12 ,pp. : 199-204

Informa Healthcare

Access to resources Recommend Favorite

A pharmacokinetic study with a low-dose oral contraceptive containing 20 μg ethinylestradiol plus 100 μg levonorgestrel

By Endrikat J.   Blode H.   Gerlinger C.   Rosenbaum P.   Kuhnz W.  

The European Journal of Contraception and Reproductive Health Care, Vol. 7, Iss. 2, 2002-06 ,pp. : 79-90

Informa Healthcare

Access to resources Recommend Favorite

Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 g ethinyl estradiol combined with 150 g desogestrel or 75 g gestodene

By Zichella L.  

Advances in Contraception, Vol. 15, Iss. 3, 1999-01 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite

Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 g or 30 g) and levonorgestrel (100 g or 150 g) on lipoprotein metabolism

By Scharnagl H.   Petersen G.   Nauck M.   Teichmann A.T.   Wieland H.   Marz W.  

Contraception, Vol. 69, Iss. 2, 2004-02 ,pp. : 105-113

Elsevier

Access to resources Recommend Favorite

The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive

By Zimmerman Yvette   Coelingh Bennink Herjan J. T.   Wouters Wout   Ebes Frieda   Fauser Bart C. J. M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 6, 2013-12 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite